Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673170 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Somatostatin Receptor 1 (SSTR1) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human SSTR1, identical to the related rat and mouse sequences.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts.
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
THE BLOOD LIPIDS IN THE POSTABSORPTIVE STATE AND AFTER THE INGESTION OF FAT IN NORMAL HUMAN SUBJECTS AND IN A CASE OF DISSEMINATED CUTANEOUS XANTHOMATA.
Xie Y, Chen S, Wang CH, Tang CW
Cancer biology & therapy 2011 Jul 1;12(1):86-92
Cancer biology & therapy 2011 Jul 1;12(1):86-92
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y
The Journal of clinical investigation 1994 Mar;93(3):1321-5
The Journal of clinical investigation 1994 Mar;93(3):1321-5
THE BLOOD LIPIDS IN THE POSTABSORPTIVE STATE AND AFTER THE INGESTION OF FAT IN NORMAL HUMAN SUBJECTS AND IN A CASE OF DISSEMINATED CUTANEOUS XANTHOMATA.
Chaikoff IL, McGavack TH, Kaplan A
The Journal of clinical investigation 1934 Jan;13(1):1-13
The Journal of clinical investigation 1934 Jan;13(1):1-13
No comments: Submit comment
No validations: Submit validation data